Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Balk

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Cell Biochemistry and Biophysics|February 4, 2006
Altered chemokine receptor profile on circulating leukocytes in human heart failurePetros Athanassopoulos, Leonard M B Vaessen, Aggie H M M Balk, et al.
Journal of Psychosomatic Research|December 5, 2006
Type D personality is associated with impaired health-related quality of life 7 years following heart transplantationSusanne S Pedersen, Pieter G Holkamp, Kadir Caliskan, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2003
[Twenty-five years of cyclosporin use in transplantation medicine]D A Hesselink, P M van Hagen, A H M M Balk, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2004
Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responsesPetros Athanassopoulos, Leonard M B Vaessen, Alex P W M Maat, et al.
Transplantation|April 23, 2009
Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejectionI Esmé Dijke, Sander S Korevaar, Kadir Caliskan, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 3, 2016
Cardiac allograft vasculopathy in Dutch heart transplant recipientsG Galli, K Caliskan, A H M M Balk, et al.
The American Journal of Cardiology|August 14, 2012
Frequency of asymptomatic disease among family members with noncompaction cardiomyopathyKadir Caliskan, Michelle Michels, Marcel L Geleijnse, et al.
International Journal of Cardiology|February 5, 2008
Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathyPetros Athanassopoulos, Aggie H M M Balk, Leonard M B Vaessen, et al.
Transplantation Proceedings|August 15, 2002
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta systemI C van Riemsdijk, C C Baan, A H M M Balk, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2006
Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patientsI Esmé Dijke, Jurjen H L Velthuis, Aggie H M M Balk, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Cell Biochemistry and Biophysics|February 4, 2006
Altered chemokine receptor profile on circulating leukocytes in human heart failurePetros Athanassopoulos, Leonard M B Vaessen, Aggie H M M Balk, et al.
Journal of Psychosomatic Research|December 5, 2006
Type D personality is associated with impaired health-related quality of life 7 years following heart transplantationSusanne S Pedersen, Pieter G Holkamp, Kadir Caliskan, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 6, 2003
[Twenty-five years of cyclosporin use in transplantation medicine]D A Hesselink, P M van Hagen, A H M M Balk, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|March 24, 2004
Peripheral blood dendritic cells in human end-stage heart failure and the early post-transplant period: evidence for systemic Th1 immune responsesPetros Athanassopoulos, Leonard M B Vaessen, Alex P W M Maat, et al.
Transplantation|April 23, 2009
Inadequate immune regulatory function of CD4+CD25bright+FoxP3+ T cells in heart transplant patients who experience acute cellular rejectionI Esmé Dijke, Sander S Korevaar, Kadir Caliskan, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|September 3, 2016
Cardiac allograft vasculopathy in Dutch heart transplant recipientsG Galli, K Caliskan, A H M M Balk, et al.
The American Journal of Cardiology|August 14, 2012
Frequency of asymptomatic disease among family members with noncompaction cardiomyopathyKadir Caliskan, Michelle Michels, Marcel L Geleijnse, et al.
International Journal of Cardiology|February 5, 2008
Blood dendritic cell levels and phenotypic characteristics in relation to etiology of end-stage heart failure: implications for dilated cardiomyopathyPetros Athanassopoulos, Aggie H M M Balk, Leonard M B Vaessen, et al.
Transplantation Proceedings|August 15, 2002
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta systemI C van Riemsdijk, C C Baan, A H M M Balk, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|August 8, 2006
Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patientsI Esmé Dijke, Jurjen H L Velthuis, Aggie H M M Balk, et al.
Pageof 7